These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36042628)

  • 1. Correlations of ALD, Keap-1, and FoxO4 expression with traditional tumor markers and clinicopathological characteristics in colorectal carcinoma.
    Huang P; Wang S; Wu Z; Zhou Z; Kuang M; Ren C; Qian X; Jiang A; Zhou Y; Wang X; Shao G
    Medicine (Baltimore); 2022 Aug; 101(34):e30222. PubMed ID: 36042628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer.
    Wang Y; Kang XL; Zeng FC; Xu CJ; Zhou JQ; Luo DN
    Pathol Res Pract; 2017 Jul; 213(7):766-772. PubMed ID: 28554751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXO4 interacts with p53 TAD and CRD and inhibits its binding to DNA.
    Mandal R; Kohoutova K; Petrvalska O; Horvath M; Srb P; Veverka V; Obsilova V; Obsil T
    Protein Sci; 2022 May; 31(5):e4287. PubMed ID: 35481640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical investigation of the dual binding surfaces of human transcription factors FOXO4 and p53.
    Kim J; Ahn D; Park CJ
    FEBS J; 2022 Jun; 289(11):3163-3182. PubMed ID: 34954873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forkhead box O4 transcription factor in human neoplasms: Cannot afford to lose the novel suppressor.
    Lu C; Yang Z; Jiang S; Yang Y; Han Y; Lv J; Li T; Chen F; Yu Y
    J Cell Physiol; 2019 Jun; 234(6):8647-8658. PubMed ID: 30515801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXO4 Inhibits the Migration and Metastasis of Colorectal Cancer by Regulating the
    Sun Y; Wang L; Xu X; Han P; Wu J; Tian X; Li M
    Front Cell Dev Biol; 2021; 9():659731. PubMed ID: 34631691
    [No Abstract]   [Full Text] [Related]  

  • 7. FOXO4 ameliorates alcohol-induced chronic liver injury via inhibiting NF-κB and modulating gut microbiota in C57BL/6J mice.
    Sang L; Kang K; Sun Y; Li Y; Chang B
    Int Immunopharmacol; 2021 Jul; 96():107572. PubMed ID: 33798806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.
    Jin M; Long ZW; Yang J; Lin X
    Pathol Oncol Res; 2018 Jan; 24(1):45-57. PubMed ID: 28188432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2/P-glycoprotein axis is associated with clinicopathological characteristics in colorectal cancer.
    Sadeghi MR; Jeddi F; Soozangar N; Somi MH; Shirmohamadi M; Khaze V; Samadi N
    Biomed Pharmacother; 2018 Aug; 104():458-464. PubMed ID: 29793178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability.
    Brändstedt J; Wangefjord S; Nodin B; Eberhard J; Jirström K; Manjer J
    BMC Cancer; 2014 May; 14():371. PubMed ID: 24885829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current perspective on the regulation of FOXO4 and its role in disease progression.
    Liu W; Li Y; Luo B
    Cell Mol Life Sci; 2020 Feb; 77(4):651-663. PubMed ID: 31529218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1q/tumor necrosis factor-related protein-3 (CTRP3) activated by forkhead box O4 (FOXO4) down-regulation protects retinal pericytes against high glucose-induced oxidative damage through nuclear factor erythroid 2-related factor 2 (Nrf2)/Nuclear factor-kappaB (NF-κB) signaling.
    Zeng X; Peng Y; Wang Y; Kang K
    Bioengineered; 2022 Mar; 13(3):6080-6091. PubMed ID: 35196182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus.
    Chuang PY; Dai Y; Liu R; He H; Kretzler M; Jim B; Cohen CD; He JC
    PLoS One; 2011; 6(8):e23566. PubMed ID: 21858169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
    Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J
    Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of FOXO4 Inhibits Cholangiocarcinoma Cell Proliferation
    Intuyod K; Chomwong S; Thongpon P; Vaeteewoottacharn K; Pairojkul C; Pinlaor P; Pinlaor S
    Anticancer Res; 2020 Dec; 40(12):6899-6905. PubMed ID: 33288583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new model for raf kinase inhibitory protein induced chemotherapeutic resistance.
    Al-Mulla F; Bitar MS; Feng J; Park S; Yeung KC
    PLoS One; 2012; 7(1):e29532. PubMed ID: 22279539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients.
    Li J; Jiang Z; Han F; Liu S; Yuan X; Tong J
    Oncotarget; 2016 May; 7(18):25585-92. PubMed ID: 27027443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53.
    Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X
    Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-328-3p Protects Vascular Endothelial Cells Against Oxidized Low-Density Lipoprotein Induced Injury via Targeting Forkhead Box Protein O4 (FOXO4) in Atherosclerosis.
    Qin X; Guo J
    Med Sci Monit; 2020 Apr; 26():e921877. PubMed ID: 32329448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_UBR4 Knockdown Alleviates Oxidized Low-Density Lipoprotein-Provoked Growth and Migration of Human Vascular Smooth Muscle Cells by Acting on the miR-637/FOXO4 Pathway.
    Ding Y; Tang T; Lu J; Wang J
    J Cardiovasc Pharmacol; 2021 Oct; 78(4):534-543. PubMed ID: 34225339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.